Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 31/08/21 → 31/12/24 |
Keywords
- Acute Myeloid Leukemia
- Haematological malignancy
- Clinical trial
- Blood cancer
Clinical Trial Phase
- Phase III (a & b)
A Phase 3, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination with Azacitidine versus Physician's Choice of Venetoclax in Combination with Azacitidine or Intensive Chemotherapy in Previously Untreated Patients with TP53 Mutant Acute Myeloid Leukemia
- Wei, Andrew (Primary Chief Investigator (PCI))
- Hodges, Georgina (Chief Investigator (CI))
- Purtill, Duncan (Chief Investigator (CI))
- Bennett, Sam (Chief Investigator (CI))
- Hiwase, Devendra Keshaorao (Chief Investigator (CI))
- Tate, Courtney (Chief Investigator (CI))
- Enjeti, Anoop Kumar (Chief Investigator (CI))
- Bhattacharyya, Abir (Chief Investigator (CI))
- Tan, Peter (Chief Investigator (CI))
Project: Research